Join
Live feed
·
PRReleasevia Quantisnow
Cidara Therapeutics Inc. logo

Cidara Therapeutics Submits NDA for Rezafungin and Announces License Agreement with Melinta Therapeutics for Commercialization of Rezafungin in the U.S.

ByQuantisnow·Wall Street's wire, on your screen.
CDTX· Cidara Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CDTX (Cidara Therapeutics Inc.) and more on Quantisnow.